Show simple item record

dc.contributor.authorCREAGH, EMMAen
dc.contributor.authorMARTIN, SEAMUSen
dc.date.accessioned2012-01-23T11:29:01Z
dc.date.available2012-01-23T11:29:01Z
dc.date.issued2001en
dc.date.submitted2001en
dc.identifier.citationBouchier-Hayes L, Conroy H, Egan H, Adrain C, Creagh EM, MacFarlane M, Martin SJ, CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways., The Journal of biological chemistry, 276, 47, 2001, 44069-77en
dc.identifier.issn0021-9258en
dc.identifier.otherYen
dc.identifier.urihttp://hdl.handle.net/2262/61799
dc.descriptionPUBLISHEDen
dc.description.abstractProteins possessing the caspase recruitment domain (CARD) motif have been implicated in pathways leading to activation of caspases or NF-kappaB in the context of apoptosis or inflammation, respectively. Here we report the identification of a novel protein, CARDINAL, that contains a CARD motif and also exhibits a high degree of homology to the C terminus of DEFCAP/NAC, a recently described member of the Apaf-1/Nod-1 family. In contrast with the majority of CARD proteins described to date, CARDINAL failed to promote apoptosis or NF-kappaB activation. Rather, CARDINAL potently suppressed NF-kappaB activation associated with overexpression of TRAIL-R1, TRAIL-R2, RIP, RICK, Bcl10, and TRADD, or through ligand-induced stimulation of the interleukin-1 or tumor necrosis factor receptors. Co-immunoprecipitation experiments revealed that CARDINAL interacts with the regulatory subunit of the IkappaB kinase (IKK) complex, IKKgamma (NEMO), providing a molecular basis for CARDINAL function. Thus, CARDINAL is a novel regulator of NF-kappaB activation in the context of pro-inflammatory signals.en
dc.format.extent44069-77en
dc.language.isoenen
dc.relation.ispartofseriesThe Journal of biological chemistryen
dc.relation.ispartofseries276en
dc.relation.ispartofseries47en
dc.rightsYen
dc.subjectBiochemistryen
dc.subjectcaspase recruitment domain (CARD)en
dc.titleCARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways.en
dc.typeJournal Articleen
dc.contributor.sponsorEuropean Union (EU)en
dc.contributor.sponsorWellcome Trusten
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/martinsjen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/ecreaghen
dc.identifier.rssinternalid77298en
dc.identifier.doihttp://dx.doi.org/10.1074/jbc.M107373200en
dc.relation.ecprojectidinfo:eu-repo/grantAgreement/EC/FP7/1999-00739
dc.contributor.sponsorGrantNumber1999-00739en
dc.contributor.sponsorGrantNumber047580en
dc.subject.TCDThemeGenes & Societyen
dc.subject.TCDThemeImmunology, Inflammation & Infectionen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record